These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 25813250

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L, Brown I, Schofield AC.
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [Abstract] [Full Text] [Related]

  • 3. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.
    Zhang Y, Wang Y, Wei Y, Li M, Yu S, Ye M, Zhang H, Chen S, Liu W, Zhang J.
    Sci Rep; 2015 Oct 21; 5():15424. PubMed ID: 26487539
    [Abstract] [Full Text] [Related]

  • 4. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
    Zhang HD, Sun DW, Mao L, Zhang J, Jiang LH, Li J, Wu Y, Ji H, Chen W, Wang J, Ma R, Cao HX, Wu JZ, Tang JH.
    Biochem Biophys Res Commun; 2015 Oct 02; 465(4):702-13. PubMed ID: 26299922
    [Abstract] [Full Text] [Related]

  • 5. miR-141 regulation of EIF4E expression affects docetaxel chemoresistance of non-small cell lung cancer.
    Wang D, Ma J, Ji X, Xu F, Wei Y.
    Oncol Rep; 2017 Jan 02; 37(1):608-616. PubMed ID: 27840955
    [Abstract] [Full Text] [Related]

  • 6. Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer.
    Gu X, Xue JQ, Han SJ, Qian SY, Zhang WH.
    Cancer Biomark; 2016 Jan 02; 16(3):395-403. PubMed ID: 27062696
    [Abstract] [Full Text] [Related]

  • 7. Potentiation of docetaxel sensitivity by miR-638 via regulation of STARD10 pathway in human breast cancer cells.
    Zhao G, Li Y, Wang T.
    Biochem Biophys Res Commun; 2017 May 27; 487(2):255-261. PubMed ID: 28412359
    [Abstract] [Full Text] [Related]

  • 8. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
    Zhong S, Li W, Chen Z, Xu J, Zhao J.
    Gene; 2013 Nov 15; 531(1):8-14. PubMed ID: 23994196
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
    Yang G, Wu D, Zhu J, Jiang O, Shi Q, Tian J, Weng Y.
    Oncol Rep; 2013 Aug 15; 30(2):877-89. PubMed ID: 23760062
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway.
    Zhang X, Zhong S, Xu Y, Yu D, Ma T, Chen L, Zhao Y, Chen X, Yang S, Wu Y, Tang J, Zhao J.
    PLoS One; 2016 Aug 15; 11(4):e0153194. PubMed ID: 27045586
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2).
    Hu H, Li S, Cui X, Lv X, Jiao Y, Yu F, Yao H, Song E, Chen Y, Wang M, Lin L.
    J Biol Chem; 2013 Apr 19; 288(16):10973-85. PubMed ID: 23436656
    [Abstract] [Full Text] [Related]

  • 13. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
    Feng B, Wang R, Chen LB.
    Cancer Lett; 2012 Apr 28; 317(2):184-91. PubMed ID: 22120675
    [Abstract] [Full Text] [Related]

  • 14. MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel.
    Yang F, Luo LJ, Zhang L, Wang DD, Yang SJ, Ding L, Li J, Chen D, Ma R, Wu JZ, Tang JH.
    Gene; 2017 Feb 05; 600():21-28. PubMed ID: 27913185
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1.
    Yi D, Xu L, Wang R, Lu X, Sang J.
    Cell Biol Int; 2019 Jan 05; 43(1):12-21. PubMed ID: 30444043
    [Abstract] [Full Text] [Related]

  • 17. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
    Lv J, Fu Z, Shi M, Xia K, Ji C, Xu P, Lv M, Pan B, Dai L, Xie H.
    Biomed Pharmacother; 2015 Feb 05; 69():162-9. PubMed ID: 25661353
    [Abstract] [Full Text] [Related]

  • 18. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4.
    Feng X, Zhao L, Gao S, Song X, Dong W, Zhao Y, Zhou H, Cheng L, Miao X, Jia L.
    Gene; 2016 Mar 10; 578(2):232-41. PubMed ID: 26701615
    [Abstract] [Full Text] [Related]

  • 19. RPN2 gene confers docetaxel resistance in breast cancer.
    Honma K, Iwao-Koizumi K, Takeshita F, Yamamoto Y, Yoshida T, Nishio K, Nagahara S, Kato K, Ochiya T.
    Nat Med; 2008 Sep 10; 14(9):939-48. PubMed ID: 18724378
    [Abstract] [Full Text] [Related]

  • 20. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells.
    Kastl L, Brown I, Schofield AC.
    Int J Oncol; 2010 May 10; 36(5):1235-41. PubMed ID: 20372798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.